U.S. health authorities are signing off on human trials of CBD to treat opioid addiction. The U.S. Food and Drug Administration gave the green light this week to Ananda Scientific to start human testing of its CBD drug Nantheia ATL5, the company announced. The trials will be run out of UCLA and are funded by
Infused Products & Extraction
A version of this story first appeared at MJBizDaily. The world’s leading brewer, AB InBev, and Canada’s leading cannabis producer by market share, Tilray, have ended their partnership making CBD- and THC-infused beverages. The joint venture, Fluent Beverage Co., will continue as a subsidiary of Labatt Breweries of Canada, one of AB InBev’s Canadian subsidiaries,
More research saying cannabinoids may protect human cells from COVID-19 was released this week from scientists in Ontario working with synthetic CBD. Researchers at the University of Waterloo reported in a pre-peer-reviewed study that the synthetic CBD “appears to prime the innate immune system of cells, potentially offering protection against pathogens such as SARS-CoV-2,” the
Australian marijuana producer Creso Pharma Ltd. is the latest company entering the United States via a CBD maker. Creso Pharma announced this week that it is buying Sierra Sage Herbs in an all-stock deal worth $21 million. Based in Lyons, Colorado, Sierra Sage Herbs makes a range of wellness products including some with and without